Newsletter | December 11, 2025

12.11.25 -- The 9 Fastest-Growing Outsourcing Segments

FOCUS ON OUTSOURCING

The 9 Fastest-Growing Outsourcing Segments

Capacity isn’t the choke point—capability is; this piece ranks nine fast-growing outsourcing segments and shows sponsors how to win by locking in modality-proven partners early.

Redefining CAR-T Speed And Strength: A Conversation

Discover how an autologous CAR-T platform is addressing challenges in cell therapy manufacturing. A three-day process shortens cycles, improves T-cell potency and durability, and reduces costs.

Unravelling The Complexities Of ADC Manufacturing

Whether you're in the early stages of development or scaling up for commercialization, understanding ADC manufacturing challenges is essential for bringing life-saving therapies to patients worldwide.

Protein Stress Testing

Start your forced degradation studies early to uncover molecular risks, strengthen product stability, and ensure regulatory-ready development from the start.

Application Of Plant And Process Models

Explore innovative process and facility models that optimize efficiency, sustainability, and cost-effectiveness in biopharmaceutical manufacturing.

Does Your CDMO Have An Analytical Edge?

Due to the complexity of biologics, precise analytical technology is crucial throughout every phase of drug development to ensure the highest standards of quality, safety, and regulatory compliance.

A Guide To Optimize Analytical Strategies In Biologics Development

A miscalculated analytical approach can be costly to develop, perform, and maintain. Many organizations also lack appropriate resources to create optimal testing methods and protocols.

Plasmid Engineering To Improve AAV Productivity And Packaging Efficiency

Review how you can significantly increase AAV productivity and packaging efficiency for various AAV serotypes and client-specific Genes of Interest (GOIs) at the upstream production stage through plasmid engineering approaches.

Enabling Cell Line Tech Transfer For mAb Platform Manufacturing

Technology transfer, the transmission of bioprocess knowledge, skills, and technology, is a crucial mechanism for ensuring adequate and timely access to innovative medicines.

Cytokines For Ex Vivo Cell Culture

Comparable T cell expansion and function between cytokine sources were demonstrated. Generated CAR-T cells showed robust cytotoxicity and lower exhaustion markers.

BD Vystra Disposable Pen

BD Vystra Disposable Pen is a proven, globally adopted drug delivery platform with over 175 million units sold, supporting diverse therapies in 40+ countries.

How To Choose The Right CDMO Partner For Fill & Finish

CDMO selection requires evaluating experience, quality standards, and flexibility. Assess technical transfer skills, supply chain security, and collaborative approach for a reliable, long-term project fit.

OUTSOURCING SOLUTIONS

Capacity Update October 2025: Analytical Services - Mabion

Capacity Update October 2025: Large Molecule - AGC Biologics

Gene Therapy, Oncolytic Viruses, Vaccines CDMO Services - FUJIFILM Biotechnologies

Developing A mAb For A Small Biotech Developing Precision Medicines - Lonza

Trusted End-To-End CDMO Partner For Your Journey - Samsung Biologics

AAV Production: Your AAV CDMO Partner, Every Batch, Every Milestone - MilliporeSigma

UpTempo℠ AAV Platform Process - Catalent

Connect With Bioprocess Online: